NCT07008508 2025-06-06
BRAVE-Cyclin
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Active not recruiting
Clinical Trials
6 trialsNCT06805812 2025-02-03
PALMARES-2
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Recruiting
NCT06587789 2024-11-21
Ribociclib in Combination With Adjuvant Endocrine Therapy for Patients With Early High-risk HR+HER2- Breast Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Recruiting
NCT06367335 2024-04-16
ETIC
University of Milano Bicocca
Completed
NCT05051956 2021-09-21
Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?
Namik Kemal University
Unknown
NCT04852081 2021-04-21
Analysis of Therapy Sequence in Women With HR+, HER2 - mBC in Moscow: A Multicenter Retrospective Observational Study.
Blokhin's Russian Cancer Research Center
Unknown